Patrick C. Gedeon - Concepedia

Author

Patrick C. Gedeon

Duke University ORCID

Also Known As

P GEDEON, P. C. Gedeon, P. Gedeon, P.C. Gedeon, Patrick C Gedeon, Patrick C. Gedeon, Patrick Gedeon, Patrick C. Gedeon

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Duke University Duke Medical Center Duke University Hospital Duquesne University

About

Patrick C. Gedeon is an author at Duke University specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	321
2	Immunology	4	4	246
3	Cell Biology	2	2	117
4	Biochemistry	1	1	42
5	Molecular Biology	1	1	33

Patrick C. Gedeon

Publications

854

Citations

H-Index

Page 1

	Year	Citations
Systemic administration of a bispecific antibody targeting EGFRvIII successfully treats intracerebral glioma Bryan D. Choi, Chien‐Tsun Kuan, Mingqing Cai, Proceedings of the National Academy of Sciences	2012	130
Intracerebral delivery of a third generation EGFRvIII-specific chimeric antigen receptor is efficacious against human glioma Bryan D. Choi, Carter M. Suryadevara, Patrick C. Gedeon, Journal of Clinical Neuroscience Neuro-oncologyMedicineImmunologyIntracerebral DeliveryBrain-immune Interaction	2013	107
Dendritic Cells Enhance Polyfunctionality of Adoptively Transferred T Cells That Target Cytomegalovirus in Glioblastoma Elizabeth A. Reap, Carter M. Suryadevara, Kristen A. Batich, Cancer Research	2017	105
Temozolomide lymphodepletion enhances CAR abundance and correlates with antitumor efficacy against established glioblastoma Carter M. Suryadevara, Rupen Desai, Melissa L. Abel, OncoImmunology	2018	100
Human Regulatory T Cells Kill Tumor Cells through Granzyme-Dependent Cytotoxicity upon Retargeting with a Bispecific Antibody Bryan D. Choi, Patrick C. Gedeon, James E. Herndon, Cancer Immunology Research Human Cd4Cancer ImmunosurveillanceGliomaGranzyme-dependent CytotoxicityBispecific Antibody	2013	80
Preventing Lck Activation in CAR T Cells Confers Treg Resistance but Requires 4-1BB Signaling for Them to Persist and Treat Solid Tumors in Nonlymphodepleted Hosts Carter M. Suryadevara, Rupen Desai, S. Harrison Farber, Clinical Cancer Research	2018	66
A Rationally Designed Fully Human EGFRvIII:CD3-Targeted Bispecific Antibody Redirects Human T Cells to Treat Patient-derived Intracerebral Malignant Glioma Patrick C. Gedeon, Teilo Schaller, Satish K. Chitneni, Clinical Cancer Research	2018	55
Accelerated Molecular Dynamics and Protein Conformational Change: A Theoretical and Practical Guide Using a Membrane Embedded Model Neurotransmitter Transporter Patrick C. Gedeon, James R. Thomas, Jeffry D. Madura Methods in molecular biology Biophysical ModelingProteinlipid InteractionBiochemistryProtein FoldingMembrane Transport	2014	42
Molecular dynamics of leucine and dopamine transporter proteins in a model cell membrane lipid bilayer Patrick C. Gedeon, Martín Indarte, Christopher K. Surratt, Proteins Structure Function and Bioinformatics	2009	40
Regulatory T cells are redirected to kill glioblastoma by an EGFRvIII-targeted bispecific antibody Bryan D. Choi, Patrick C. Gedeon, Luis Sánchez-Pérez, OncoImmunology Neuro-oncologyCancer ImmunosurveillanceGliomaT-regulatory CellImmunology	2013	37

Page 1